Cell host & microbePub Date : 2026-07-08Epub Date: 2026-06-04DOI: 10.1016/j.chom.2026.05.007
Animesh A Mishra, Suzette N Palmer, Christina M Zarek, Laura A Coughlin, Nicole Poulides, Jana Dakour, Rebecca S Chiu, Parastoo Sabaeifard, Wenling Li, Aidan C Morrill, Jiwoong Kim, Shuheng Gan, Cassie L Behrendt, Monika I Antczak, Xiaowei Zhan, Sebastian E Winter, Joseph M Ready, Lora V Hooper, Andrew Y Koh
{"title":"Microbiota-derived short-chain fatty acids mediate Candida albicans gastrointestinal colonization resistance.","authors":"Animesh A Mishra, Suzette N Palmer, Christina M Zarek, Laura A Coughlin, Nicole Poulides, Jana Dakour, Rebecca S Chiu, Parastoo Sabaeifard, Wenling Li, Aidan C Morrill, Jiwoong Kim, Shuheng Gan, Cassie L Behrendt, Monika I Antczak, Xiaowei Zhan, Sebastian E Winter, Joseph M Ready, Lora V Hooper, Andrew Y Koh","doi":"10.1016/j.chom.2026.05.007","DOIUrl":"10.1016/j.chom.2026.05.007","url":null,"abstract":"<p><p>The gut microbiota plays critical roles in constraining Candida albicans colonization of the gastrointestinal (GI) tract, which is a key precursor to disseminated fungal infection in immunocompromised hosts. Depletion of commensal microbiota, such as by antibiotic treatment, increases C. albicans burden and promotes dissemination, yet the mechanisms of colonization resistance remain unclear. Here, we show that microbiota-derived short-chain fatty acids (SCFAs) directly inhibit C. albicans growth by inducing fungal metabolic reprogramming, impairing hexose uptake, and inducing intracellular acidification. In vivo, SCFAs enhance Candida colonization resistance only in the presence of an intact gut microbiome, which drives SCFA-induced taxonomic shifts that augment resistance. A Bacteroides thetaiotaomicron mutant unable to produce SCFAs exhibits diminished capacity to restrict C. albicans colonization, while prebiotic therapy that increases luminal SCFAs enhances C. albicans clearance. These findings define a critical microbiota-metabolite mechanism underlying Candida colonization resistance and suggest strategies to modulate GI fungal burden and prevent invasive disease.</p>","PeriodicalId":93926,"journal":{"name":"Cell host & microbe","volume":" ","pages":"1302-1319.e11"},"PeriodicalIF":18.7,"publicationDate":"2026-07-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148165936","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Cell host & microbePub Date : 2026-07-08Epub Date: 2026-06-11DOI: 10.1016/j.chom.2026.05.015
Ryan T Bell, Thomas Gaudin, Yi Wu, Sofya K Garushyants, Harutyun Sahakyan, Kira S Makarova, Yuri I Wolf, Simon A Jackson, Franklin L Nobrega, Chase L Beisel, Eugene V Koonin
{"title":"YprA-family helicases provide the missing link between diverse prokaryotic immune systems.","authors":"Ryan T Bell, Thomas Gaudin, Yi Wu, Sofya K Garushyants, Harutyun Sahakyan, Kira S Makarova, Yuri I Wolf, Simon A Jackson, Franklin L Nobrega, Chase L Beisel, Eugene V Koonin","doi":"10.1016/j.chom.2026.05.015","DOIUrl":"10.1016/j.chom.2026.05.015","url":null,"abstract":"<p><p>Bacteria and archaea possess an enormous variety of antiviral immune systems that often share homologous proteins and domains. YprA-family helicases are central to widespread defense systems, which include defense island system associated with restriction-modification (DISARM), 7-deazapurine in DNA (Dpd), and Druantia. Through comprehensive phylogenetic and structural analyses of YprA-like helicases, we identify several major clades, which define distinct defense systems including a broad class we call ARMADA (disARM-related antiviral defense array). Apart from the YprA-like helicase, ARMADAs share two more proteins with DISARM, but their YprA homologs are most similar to those of Druantia, which suggests that ARMADA is a missing link connecting DISARM and Druantia. We show experimentally that ARMADA protects bacteria against a broad range of phages via a direct, non-abortive mechanism. We further demonstrate that ARMADA and Druantia Type III systems often co-occur within distinct satellite phage-like mobile elements, which we call SPIDERs (satellite phage integrated defensive and ecotypic replicons) and which provide synergistic resistance against diverse phages.</p>","PeriodicalId":93926,"journal":{"name":"Cell host & microbe","volume":" ","pages":"1430-1444.e3"},"PeriodicalIF":18.7,"publicationDate":"2026-07-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148229599","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Cell host & microbePub Date : 2026-07-08Epub Date: 2026-06-02DOI: 10.1016/j.chom.2026.05.021
Maria C Hesselman, Marius Zeeb, Peter Rusert, Chloé Pasin, Jennifer Mamrosh, Samuel Kariuki, Ian Pichler, Michèle Sickmann, Masako M Kaufmann, Daniel Schmidt, Nikolas Friedrich, Karin J Metzner, Audrey Rindler, Herbert Kuster, Craig Adams, Ruwayhida Thebus, Michael Huber, Sabine Yerly, Karoline Leuzinger, Matthieu Perreau, Roger Koller, Günter Dollenmaier, Simona Frigerio, Dylan H Westfall, Wenjie Deng, Allan C deCamp, Michal Juraska, Srilatha Edupuganti, Nyaradzo Mgodi, Hugh Murrell, Nigel Garrett, Kshitij Wagh, James I Mullins, Carolyn Williamson, Penny L Moore, Huldrych F Günthard, Roger D Kouyos, Alexandra Trkola
{"title":"Rare twin cysteine residues in the HIV-1 envelope variable region 1 link to neutralization escape and breadth development.","authors":"Maria C Hesselman, Marius Zeeb, Peter Rusert, Chloé Pasin, Jennifer Mamrosh, Samuel Kariuki, Ian Pichler, Michèle Sickmann, Masako M Kaufmann, Daniel Schmidt, Nikolas Friedrich, Karin J Metzner, Audrey Rindler, Herbert Kuster, Craig Adams, Ruwayhida Thebus, Michael Huber, Sabine Yerly, Karoline Leuzinger, Matthieu Perreau, Roger Koller, Günter Dollenmaier, Simona Frigerio, Dylan H Westfall, Wenjie Deng, Allan C deCamp, Michal Juraska, Srilatha Edupuganti, Nyaradzo Mgodi, Hugh Murrell, Nigel Garrett, Kshitij Wagh, James I Mullins, Carolyn Williamson, Penny L Moore, Huldrych F Günthard, Roger D Kouyos, Alexandra Trkola","doi":"10.1016/j.chom.2026.05.021","DOIUrl":"10.1016/j.chom.2026.05.021","url":null,"abstract":"","PeriodicalId":93926,"journal":{"name":"Cell host & microbe","volume":" ","pages":"1477-1484"},"PeriodicalIF":18.7,"publicationDate":"2026-07-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13621955/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148151376","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Evolution of antifungal drug resistance: Challenges and mitigations.","authors":"Yunjin Lee, Nicole Robbins, Leah E Cowen","doi":"10.1016/j.chom.2026.05.018","DOIUrl":"https://doi.org/10.1016/j.chom.2026.05.018","url":null,"abstract":"<p><p>Antifungal drug resistance is a rising global health concern due to the scarce arsenal of clinically available drugs and the emergence of multidrug-resistant pathogens. Here, we discuss the mechanisms governing antifungal resistance development and emerging therapeutic strategies to thwart the evolution of resistance in human fungal pathogens.</p>","PeriodicalId":93926,"journal":{"name":"Cell host & microbe","volume":"34 7","pages":"1181-1185"},"PeriodicalIF":18.7,"publicationDate":"2026-07-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148414143","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Cell-to-cell spread primes the nuclear pore for HIV-1.","authors":"Francesca Di Nunzio","doi":"10.1016/j.chom.2026.05.028","DOIUrl":"https://doi.org/10.1016/j.chom.2026.05.028","url":null,"abstract":"<p><p>Cell-to-cell spread reprograms resting CD4⁺ T cells to permit infection. Mesner et al. show that contact between infected and uninfected T cells triggers CD4-LCK signaling, activating CDK1 independently of cell-cycle entry to remodel the nuclear pore, enabling HIV-1 nuclear import and overcoming a major barrier in resting T cells.</p>","PeriodicalId":93926,"journal":{"name":"Cell host & microbe","volume":"34 7","pages":"1383-1385"},"PeriodicalIF":18.7,"publicationDate":"2026-07-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148413829","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Decoding the microbiome: Insights into FMT for depression.","authors":"Mireia Valles-Colomer, Jane A Foster","doi":"10.1016/j.chom.2026.06.004","DOIUrl":"https://doi.org/10.1016/j.chom.2026.06.004","url":null,"abstract":"<p><p>While fecal microbiota transplantation (FMT) emerges as a promising microbiome-targeted treatment approach, its application in major depressive disorder (MDD) remains investigational. In this issue of Cell Host & Microbe, Wang et al. provide insights into the potential underpinnings of FMT in MDD and offer a step toward decoding the molecular pathways accompanying clinical response.</p>","PeriodicalId":93926,"journal":{"name":"Cell host & microbe","volume":"34 7","pages":"1154-1156"},"PeriodicalIF":18.7,"publicationDate":"2026-07-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148413833","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"A repair helicase unravels the tangled web of bacterial immunity.","authors":"Oksana Kotovskaya, Artem Isaev","doi":"10.1016/j.chom.2026.06.010","DOIUrl":"https://doi.org/10.1016/j.chom.2026.06.010","url":null,"abstract":"<p><p>DNA repair proteins are repeatedly repurposed for antiviral immunity. In this issue of Cell Host & Microbe, Bell et al. utilized phylogenetic reconstruction of the evolutionary routes of the YprA repair helicase; their study revealed the broad diversity of its genomic neighborhoods and led to the discovery of an immunity system, ARMADA (disARM-related antiviral defense array).</p>","PeriodicalId":93926,"journal":{"name":"Cell host & microbe","volume":"34 7","pages":"1392-1394"},"PeriodicalIF":18.7,"publicationDate":"2026-07-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148414383","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Cell host & microbePub Date : 2026-07-08Epub Date: 2026-05-29DOI: 10.1016/j.chom.2026.05.002
Shuaishuai Yang, Haojie Lu, Min Jin, Wei Pei, Zhen Wang, Jingjing Ni, Yuting Shi, Shuo Zhang, Yiting Li, Caiyu Li, Haoxin Sun, Xing Jia, Haizhi Deng, Hongli Liu, Li Liu
{"title":"Oat-β-glucan potentiates anti-PD-1 efficacy through Faecalibacterium prausnitzii-derived butyrate and indole-3-propionic acid.","authors":"Shuaishuai Yang, Haojie Lu, Min Jin, Wei Pei, Zhen Wang, Jingjing Ni, Yuting Shi, Shuo Zhang, Yiting Li, Caiyu Li, Haoxin Sun, Xing Jia, Haizhi Deng, Hongli Liu, Li Liu","doi":"10.1016/j.chom.2026.05.002","DOIUrl":"10.1016/j.chom.2026.05.002","url":null,"abstract":"<p><p>The gut microbiota governs immune checkpoint blockade responses, yet actionable strategies remain scarce. Here, we report that oat-β-glucan enhances anti-PD-1 (programmed cell death protein 1) efficacy in murine models by selectively expanding Faecalibacterium prausnitzii (F. prausnitzii). Combining anti-PD-1 with either oat-β-glucan or F. prausnitzii boosts intratumoral dendritic cell and CD8<sup>+</sup> T cell infiltration and cytotoxic activation compared with anti-PD-1 monotherapy. Metabolomics identifies F. prausnitzii-derived butyrate and indole-3-propionic acid (IPA) as key mediators. Mechanistically, butyrate activates dendritic cells via the histone deacetylase (HDAC)8/H3K27ac/nuclear factor κB (NF-κB) p65 pathway, while both butyrate and IPA potentiate CD8<sup>+</sup> T cell effector responses. In our colorectal cancer cohort undergoing anti-PD-1 treatment, higher baseline F. prausnitzii abundance and elevated plasma butyrate and IPA correlate with improved responses, a signature corroborated in independent external cohorts. A human intervention study confirms oat-β-glucan's safety, its ability to increase butyrate and IPA, and its capacity to modulate F. prausnitzii. Collectively, our work uncovers a microbiota-metabolite-immune axis whereby oat-β-glucan primes tumors for immunotherapy sensitization.</p>","PeriodicalId":93926,"journal":{"name":"Cell host & microbe","volume":" ","pages":"1333-1349.e10"},"PeriodicalIF":18.7,"publicationDate":"2026-07-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148058838","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Engineering plant-associated microbiome for agriculture.","authors":"Jingying Zhang, Qianhang Zhai, Yang Bai","doi":"10.1016/j.chom.2026.05.027","DOIUrl":"https://doi.org/10.1016/j.chom.2026.05.027","url":null,"abstract":"<p><p>Engineered plant-associated microbiomes provide a transformative approach for sustainable agriculture. In this Forum, we explore five strategies encompassing synthetic community design, native bacterial strain engineering, host-microbe co-adaptation, AI-driven design, and microbe-derived compounds. We assess the causes of repeated laboratory-to-field translation failures and argue for ecology-centric design principles.</p>","PeriodicalId":93926,"journal":{"name":"Cell host & microbe","volume":"34 7","pages":"1175-1180"},"PeriodicalIF":18.7,"publicationDate":"2026-07-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148414188","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Gut bacteria that produce fatty acid ethanolamides alleviate diarrhea-predominant IBS with insulin resistance.","authors":"Shujun Xu, Junfang Lyu, Gengyu Bao, Ping Zheng, Yaqi Li, Ziwan Ning, Baohua Li, Min Zhuang, Hoi Ki Wong, Mingchun Wang, Yufei Zeng, Ya Zheng, Jingyuan Luo, Qin Liu, Lu Zhang, Chengyuan Lin, Haitao Xiao, Chun-Su Yuan, Hoi Leong Xavier Wong, Zhaoxiang Bian, Lixiang Zhai","doi":"10.1016/j.chom.2026.05.020","DOIUrl":"10.1016/j.chom.2026.05.020","url":null,"abstract":"<p><p>Individuals with diarrhea-predominant irritable bowel syndrome (IBS-D) are at an increased risk of insulin resistance. Here, we identify a critical role for gut-microbe-derived fatty acid ethanolamides (FAEs) in the treatment of IBS-D with insulin resistance. In IBS-D patients with insulin resistance, serum levels of FAE are significantly reduced compared with healthy controls, and lower FAE levels negatively correlate with the severity of GI symptoms. Oral administration of FAE, specifically oleoylethanolamide (OEA), alleviates diarrhea and visceral hypersensitivity in murine IBS-D-like models. Mechanistically, OEA acts as a PPARα agonist to upregulate the serotonin transporter (SERT), limiting peripheral serotonin availability. Furthermore, fecal microbiota transplantation from high-FAE donors or treatment with FAE-producing bacteria (Escherichia coli<sup>ereT+</sup> or Eubacterium rectale) elevates fecal FAE and alleviates symptoms via the PPARα-SERT axis. Our findings reveal a microbial FAE-driven pathway linking IBS-D and insulin resistance, presenting a therapeutic target for this comorbidity. This study was registered at ClinicalTrials.gov (NCT02822677 and NCT03457324) and Chinese Clinical Trial Registry (ChiCTR2300069830 and ChiCTR2300067254).</p>","PeriodicalId":93926,"journal":{"name":"Cell host & microbe","volume":" ","pages":"1350-1366.e8"},"PeriodicalIF":18.7,"publicationDate":"2026-07-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148285021","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}